Considerations for imaging Re-188 and Re-186 isotopes

Area of Science:

• Nuclear medicine
• Radiochemistry
• Medical imaging

Background:

• Rhenium-186 (Re-186) and Rhenium-188 (Re-188) are radioisotopes with potential applications in radioimmunotherapy.
• Their energetic beta particles, imageable gamma photons, and chemical similarity to technetium make them attractive candidates.
• Previous evaluations focused on their therapeutic and imaging potential before in vivo studies.

Purpose of the Study:

• To assess the suitability of Rhenium-186 and Rhenium-188 for radioimmunotherapy.
• To determine optimal imaging parameters for these isotopes.
• To evaluate their potential for antibody imaging and therapy in patient studies.

Main Methods:

• Evaluation of the physical and chemical properties of Re-186 and Re-188.
• Investigation of imaging characteristics, including gamma photon emission.
• Determination of the required collimator energy for optimal image resolution and count rate.

Main Results:

• Re-186 and Re-188 possess energetic beta particles and imageable gamma photons.
• The presence of low-abundance, high-energy gamma photons necessitates specific collimator settings.
• A medium-energy collimator was identified as crucial for achieving optimal image resolution and count rate.

Conclusions:

• Rhenium isotopes are viable for radioimmunotherapy and diagnostic imaging.
• The selection of an appropriate collimator is critical for successful in vivo imaging with Re-186 and Re-188.
• These findings support preliminary imaging studies in patients for antibody-based therapies.